Isaac Manke - 30 Jun 2026 Form 4 Insider Report for Q32 Bio Inc. (QTTB)

Reporting relationship: Director
Issuer ticker: QTTB
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 16:30:19 UTC
Prior SEC filing: 21 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Eric Bell, Attorney-in-Fact

Key filing fact

Isaac Manke filed Form 4 for Q32 Bio Inc. (QTTB) on 02 Jul 2026.

Key facts

This page summarizes Isaac Manke's Form 4 filing for Q32 Bio Inc. (QTTB).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Jul 2026, 16:30.

Change

Previous filing in this sequence was filed on 21 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001622769 Primary reporting owner

Manke Isaac

Relationship: Director
Address: Q32 BIO INC., 830 WINTER STREET, WALTHAM
Signature: /s/ Eric Bell, Attorney-in-Fact
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QTTB transaction

Common Stock

Options Exercise

Transaction value
Shares: +53,521
Change %
Price: $2.80^*
Shares after: 53,521
Date: 30 Jun 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QTTB transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -53,521
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 53,521
Exercise price: $2.80
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option are fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .